Why Evolution, Iress, Pro Medicus, & Vicinity shares are dropping lower

Iress Ltd (ASX:IRE) and Pro Medicus Limited (ASX:PME) shares are two of four that are trading notably lower on Tuesday. Here's why…

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) has given back its morning gains and is dropping lower. At the time of writing the benchmark index is down 0.2% to 5,806.9 points.

Four shares that have not been able to follow the market higher today are listed below. Here's why they are dropping lower:

The Evolution Mining Ltd (ASX: EVN) share price has fallen 2.5% to $6.14. A slight softening of the gold price is weighing on the gold miners today. In other news, this morning Evolution responded to media speculation and confirmed that it has been evaluating the possible divestment of its Cracow gold mine.

The Iress Ltd (ASX: IRE) share price has fallen 2% to $11.00. This morning the financial technology company's shares returned from a trading halt after raising $150 million via an institutional placement. These funds were raised at $10.42 per new share, which represents a discount of 7%. The proceeds will be used to acquire Onevue Holdings Ltd (ASX: OVH).

The Pro Medicus Limited (ASX: PME) share price is down 3% to $28.48. The catalyst for this appears to be a broker note out of UBS this morning. It has downgraded the healthcare imaging software provider's shares to a neutral rating with a $29.65 price target. While the broker likes Pro Medicus and was pleased with its latest contract win, it isn't a fan of its current valuation.

The Vicinity Centres (ASX: VCX) share price has returned from its trading halt and dropped 3.5% to $1.54. This follows the completion of the shopping centre operator's $1.2 billion institutional placement. Vicinity raised the funds at $1.48 per share, which represents a discount of 8% to its last close price. The proceeds will be used to strengthen its balance sheet during the tough trading conditions it is facing.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended IRESS Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Down 30%: Why a top broker just upgraded PLS shares

Bell Potter has turned positive on this lithium miner.

Read more »

Broker looking at the share price.
ASX Share Market News

5 things to watch on the ASX 200 on Wednesday

A lot is happening on the share market today. Here's what you need to know.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a shaky, but positive, session for the ASX this Tuesday.

Read more »

Excited group of friends watching sports on TV and celebrating.
Broker Notes

4 ASX shares tipped by brokers to return 50% to 169%

Do you own any of these ASX shares in your portfolio?

Read more »

A smiling woman puts fuel into her car at a petrol pump.
Broker Notes

2 ASX energy players that could return 20% to 30% over the next year

Global uncertainty is keeping energy prices high.

Read more »

A man sitting at his dining table looks at his laptop and ponders the share price.
Broker Notes

Buy, hold, sell: Xero, Ansell, Wesfarmers shares

Let's find out what the experts are saying about Xero and two other ASX 200 shares.

Read more »

A woman holds her finger to the side of her lips in contemplation as she looks upwards to an array of graphic images of light bulbs above her head, one of which is on and glowing.
Broker Notes

CSL, Westpac, BHP shares: Buy, hold, or sell?

Find out what the experts tip for these ASX 200 giants.

Read more »

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

Could this ASX uranium developer more than double in value?

This company's African projects are shaping up well.

Read more »